ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
investment factor · long-only model fund

Foundry DelEqu Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FDERHYPOTHETICAL MODEL
Since ’99
−45%
Expense Ratio
0.35%
placeholder
Holdings
296
cap-weighted
Inception
Oct 2020
placeholder
Full Sharpe
-0.05
Ann. Return (LS)
-0.8%
Ann. Volatility
16.8%
Max Drawdown
-73.3%
Test Sharpe ’19–26
-0.18
Test FF5 α (ann.)
-1.8%
vs Fama-French 5
Test FF5 α t-stat
-0.31
not significant
Monthly turnover
20%
of the long leg, per rebalance
Cumulative return (LS)
-45%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.49
what this fund holds
Long leg ann. return
8.6%
buyable, long-only
Long-short Sharpe
-0.05
requires shorting
Bottom bucket ann. return
9.4%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

296 of 296 · 100.0% of book
TickerCompanySectorMarket capWeight
1RTX
RTX CORPIndustrials$260.60B
9.20%
2SCCO
SOUTHERN COPPER CORPBasic Materials$142.48B
5.03%
3CRM
SALESFORCE INCTechnology$139.86B
4.94%
4SYK
STRYKER CORPHealthcare$122.63B
4.33%
5ISRG
INTUITIVE SURGICAL INCHealthcare$122.33B
4.32%
6LMT
LOCKHEED MARTIN CORPIndustrials$117.30B
4.14%
7MDT
MEDTRONIC PLCHealthcare$106.50B
3.76%
8NEM
NEWMONT CORPBasic Materials$95.76B
3.38%
9FCX
FREEPORT-MCMORAN INCBasic Materials$83.92B
2.96%
10MMM
3M COIndustrials$83.37B
2.94%
11HON
HONEYWELL INTERNATIONAL INCIndustrials$71.29B
2.52%
12TDG
TRANSDIGM GROUP INCIndustrials$67.93B
2.40%
13BSX
BOSTON SCIENTIFIC CORPHealthcare$65.44B
2.31%
14EW
EDWARDS LIFESCIENCES CORPHealthcare$49.36B
1.74%
15MSCI
MSCI INCFinancial Services$45.77B
1.62%
16MCHP
MICROCHIP TECHNOLOGY INCTechnology$43.89B
1.55%
17BDX
BECTON DICKINSON & COHealthcare$43.58B
1.54%
18KDP
KEURIG DR PEPPER INCConsumer Defensive$42.05B
1.49%
19AXON
AXON ENTERPRISE INCIndustrials$41.13B
1.45%
20RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
1.40%
21VMC
VULCAN MATERIALS COBasic Materials$37.41B
1.32%
22WDAY
WORKDAY INCTechnology$35.76B
1.26%
23ON
ON SEMICONDUCTOR CORPTechnology$34.24B
1.21%
24DXCM
DEXCOM INCHealthcare$29.58B
1.04%
25FICO
FAIR ISAAC CORPTechnology$29.15B
1.03%
26RMD
RESMED INCHealthcare$28.86B
1.02%
27GEHC
GE HEALTHCARE TECHNOLOGIES INCHealthcare$28.69B
1.01%
28ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
0.94%
29VRSK
VERISK ANALYTICS INCIndustrials$26.29B
0.93%
30VRSN
VERISIGN INCTechnology$25.27B
0.89%
31MRNA
MODERNA INCHealthcare$24.53B
0.87%
32UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
0.80%
33STE
STERIS PLCHealthcare$21.26B
0.75%
34FTV
FORTIVE CORPTechnology$18.83B
0.67%
35DD
DUPONT DE NEMOURS INCBasic Materials$18.49B
0.65%
36ZBH
ZIMMER BIOMET HOLDINGS INCHealthcare$17.63B
0.62%
37BBIO
BRIDGEBIO PHARMA INCHealthcare$15.94B
0.56%
38SOLV
SOLVENTUM CORPHealthcare$14.08B
0.50%
39COO
COOPER COMPANIES INCHealthcare$13.99B
0.49%
40CSL
CARLISLE COMPANIES INCBasic Materials$13.98B
0.49%
41PINS
PINTEREST INCCommunication Services$13.00B
0.46%
42MDGL
MADRIGAL PHARMACEUTICALS INCHealthcare$12.76B
0.45%
43ALGN
ALIGN TECHNOLOGY INCHealthcare$12.66B
0.45%
44PEN
PENUMBRA INCHealthcare$12.52B
0.44%
45COKE
COCA-COLA CONSOLIDATED INCConsumer Defensive$12.03B
0.42%
46BF.B
BROWN FORMAN CORPConsumer Defensive$11.74B
0.41%
47BAX
BAXTER INTERNATIONAL INCHealthcare$11.68B
0.41%
48PODD
INSULET CORPHealthcare$11.36B
0.40%
49CART
INSTACART (MAPLEBEAR INC)Consumer Cyclical$10.77B
0.38%
50GMED
GLOBUS MEDICAL INCHealthcare$10.45B
0.37%
51CYTK
CYTOKINETICS INCHealthcare$9.98B
0.35%
52IT
GARTNER INCTechnology$9.39B
0.33%
53HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.33%
54GKOS
GLAUKOS CORPHealthcare$9.21B
0.33%
55IBRX
IMMUNITYBIO INCHealthcare$8.04B
0.28%
56RAL
RALLIANT CORPTechnology$7.85B
0.28%
57MBLY
MOBILEYE GLOBAL INCConsumer Cyclical$7.76B
0.27%
58TAP
MOLSON COORS BEVERAGE COConsumer Defensive$7.28B
0.26%
59DBX
DROPBOX INCTechnology$7.14B
0.25%
60LQDA
LIQUIDIA CORPHealthcare$7.11B
0.25%
61PAYC
PAYCOM SOFTWARE INCTechnology$7.05B
0.25%
62RIOT
RIOT PLATFORMS INCFinancial Services$6.91B
0.24%
63CHE
CHEMED CORPHealthcare$6.77B
0.24%
64CORZ
CORE SCIENTIFIC INCTechnology$6.66B
0.24%
65MSA
MSA SAFETY INCIndustrials$6.60B
0.23%
66MXL
MAXLINEAR INCTechnology$6.43B
0.23%
67CVLT
COMMVAULT SYSTEMS INCTechnology$6.10B
0.22%
68MIDD
MIDDLEBY CORPIndustrials$6.02B
0.21%
69TFX
TELEFLEX INCHealthcare$5.96B
0.21%
70BLCO
BAUSCH & LOMB CORPHealthcare$5.80B
0.20%
71CLF
CLEVELAND-CLIFFS INCBasic Materials$5.29B
0.19%
72KNF
KNIFE RIVER CORPBasic Materials$4.64B
0.16%
73LIVN
LIVANOVA PLCHealthcare$4.43B
0.16%
74LBRDA
LIBERTY BROADBAND CORPCommunication Services$4.43B
0.16%
75MDU
MDU RESOURCES GROUP INCIndustrials$4.42B
0.16%
76MMSI
MERIT MEDICAL SYSTEMS INCHealthcare$4.41B
0.16%
77NVST
ENVISTA HOLDINGS CORPHealthcare$4.35B
0.15%
78CELC
CELCUITY INCHealthcare$4.31B
0.15%
79VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.15%
80EXLS
EXLSERVICE HOLDINGS INCTechnology$4.30B
0.15%
81UCTT
ULTRA CLEAN HOLDINGS INCTechnology$4.14B
0.15%
82MARA
MARA HOLDINGS INCFinancial Services$4.08B
0.14%
83BFAM
BRIGHT HORIZONS FAMILY SOLUTIONS INCConsumer Cyclical$4.03B
0.14%
84ICUI
ICU MEDICAL INCHealthcare$3.94B
0.14%
85POWI
POWER INTEGRATIONS INCTechnology$3.93B
0.14%
86RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.13%
87LOPE
GRAND CANYON EDUCATION INCConsumer Defensive$3.72B
0.13%
88DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.13%
89IRTC
IRHYTHM HOLDINGS INCHealthcare$3.64B
0.13%
90AB
ALLIANCEBERNSTEIN HOLDING LPFinancial Services$3.54B
0.13%
91HAE
HAEMONETICS CORPHealthcare$3.54B
0.12%
92CLSK
CLEANSPARK INCFinancial Services$3.34B
0.12%
93SEDG
SOLAREDGE TECHNOLOGIES INCTechnology$3.25B
0.11%
94WRBY
WARBY PARKER INCHealthcare$3.24B
0.11%
95ACHC
ACADIA HEALTHCARE COMPANY INCHealthcare$3.17B
0.11%
96CARG
CARGURUS INCConsumer Cyclical$3.16B
0.11%
97PENG
PENGUIN SOLUTIONS INCTechnology$3.10B
0.11%
98EXPO
EXPONENT INCIndustrials$3.05B
0.11%
99AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.11%
100LUNR
INTUITIVE MACHINES INCIndustrials$2.93B
0.10%
101RARE
ULTRAGENYX PHARMACEUTICAL INCHealthcare$2.88B
0.10%
102LCID
LUCID GROUP INCConsumer Cyclical$2.87B
0.10%
103XRAY
DENTSPLY SIRONA INCHealthcare$2.81B
0.10%
104CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.10%
105ESTA
ESTABLISHMENT LABS HOLDINGS INCHealthcare$2.72B
0.10%
106GRND
GRINDR INCTechnology$2.71B
0.10%
107TMDX
TRANSMEDICS GROUP INCHealthcare$2.56B
0.09%
108DCO
DUCOMMUN INCIndustrials$2.54B
0.09%
109RUM
RUMBLE INCTechnology$2.51B
0.09%
110TALO
TALOS ENERGY INCEnergy$2.49B
0.09%
111ATRO
ASTRONICS CORPIndustrials$2.41B
0.09%
112BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.08%
113AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.08%
114BHVN
BIOHAVEN LTDHealthcare$2.32B
0.08%
115LMAT
LEMAITRE VASCULAR INCHealthcare$2.32B
0.08%
116INTA
INTAPP INCTechnology$2.24B
0.08%
117SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.08%
118NWL
NEWELL BRANDS INCConsumer Defensive$2.22B
0.08%
119AGL
AGILON HEALTH INCHealthcare$2.17B
0.08%
120CDNA
CAREDX INCHealthcare$2.05B
0.07%
121NUVB
NUVATION BIO INCHealthcare$2.03B
0.07%
122SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.07%
123PLSE
PULSE BIOSCIENCES INCHealthcare$1.98B
0.07%
124URGN
UROGEN PHARMA LTDHealthcare$1.96B
0.07%
125UFPT
UFP TECHNOLOGIES INCHealthcare$1.87B
0.07%
126MRVI
MARAVAI LIFESCIENCES HOLDINGS INCHealthcare$1.87B
0.07%
127SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.07%
128MQ
MARQETA INCTechnology$1.85B
0.07%
129NVCR
NOVOCURE LTDHealthcare$1.84B
0.07%
130FUN
SIX FLAGS ENTERTAINMENT CORPORATIONConsumer Cyclical$1.79B
0.06%
131NN
NEXTNAV INCTechnology$1.78B
0.06%
132ATRC
ATRICURE INCHealthcare$1.77B
0.06%
133ZYME
ZYMEWORKS INCHealthcare$1.77B
0.06%
134AESI
ATLAS ENERGY SOLUTIONS INCEnergy$1.76B
0.06%
135BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.06%
136FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.06%
137EYE
NATIONAL VISION HOLDINGS INCConsumer Cyclical$1.66B
0.06%
138VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.06%
139NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.06%
140ENOV
ENOVIS CORPIndustrials$1.56B
0.06%
141IART
INTEGRA LIFESCIENCES HOLDINGS CORPHealthcare$1.50B
0.05%
142CNXC
CONCENTRIX CORPTechnology$1.49B
0.05%
143PRGO
PERRIGO CO PLCHealthcare$1.48B
0.05%
144INSP
INSPIRE MEDICAL SYSTEMS INCHealthcare$1.46B
0.05%
145MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.05%
146YELP
YELP INCCommunication Services$1.44B
0.05%
147KMTS
KESTRA MEDICAL TECHNOLOGIES LTDHealthcare$1.43B
0.05%
148BLFS
BIOLIFE SOLUTIONS INCHealthcare$1.42B
0.05%
149BRBR
BELLRING BRANDS INCConsumer Defensive$1.41B
0.05%
150FMC
FMC CORPBasic Materials$1.40B
0.05%
151AI
C3AI INCTechnology$1.37B
0.05%
152CXM
SPRINKLR INCTechnology$1.37B
0.05%
153STAA
STAAR SURGICAL COHealthcare$1.32B
0.05%
154ATEC
ALPHATEC HOLDINGS INCHealthcare$1.31B
0.05%
155HLIT
HARMONIC INCTechnology$1.31B
0.05%
156CNMD
CONMED CORPHealthcare$1.30B
0.05%
157XNCR
XENCOR INCHealthcare$1.30B
0.05%
158INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.05%
159AMPL
AMPLITUDE INCTechnology$1.27B
0.04%
160CDRE
CADRE HOLDINGS INCIndustrials$1.24B
0.04%
161IRMD
IRADIMED CORPHealthcare$1.24B
0.04%
162CMP
COMPASS MINERALS INTERNATIONAL INCBasic Materials$1.24B
0.04%
163AORT
ARTIVION INCHealthcare$1.22B
0.04%
164DRTS
ALPHA TAU MEDICAL LTDHealthcare$1.19B
0.04%
165QDEL
QUIDELORTHO CORPHealthcare$1.19B
0.04%
166TNDM
TANDEM DIABETES CARE INCHealthcare$1.17B
0.04%
167AVNS
AVANOS MEDICAL INCHealthcare$1.17B
0.04%
168MYE
MYERS INDUSTRIES INCConsumer Cyclical$1.17B
0.04%
169MGTX
MEIRAGTX HOLDINGS PLCHealthcare$1.15B
0.04%
170EYPT
EYEPOINT INCHealthcare$1.12B
0.04%
171SECZ
SECURITIZE CORPTechnology$1.11B
0.04%
172PRCT
PROCEPT BIOROBOTICS CORPHealthcare$1.09B
0.04%
173PCT
PURECYCLE TECHNOLOGIES INCIndustrials$1.09B
0.04%
174CGEM
CULLINAN THERAPEUTICS INCHealthcare$1.09B
0.04%
175NMAX
NEWSMAX INCCommunication Services$1.08B
0.04%
176GRPN
GROUPON INCCommunication Services$1.06B
0.04%
177AEVA
AEVA TECHNOLOGIES INCConsumer Cyclical$1.05B
0.04%
178AVTX
AVALO THERAPEUTICS INCHealthcare$1.02B
0.04%
179PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.04%
180BVS
BIOVENTUS INCHealthcare$1.01B
0.04%
181VOR
VOR BIOPHARMA INCHealthcare$980M
0.03%
182MUX
MCEWEN INCBasic Materials$978M
0.03%
183KURA
KURA ONCOLOGY INCHealthcare$964M
0.03%
184ANNX
ANNEXON INCHealthcare$950M
0.03%
185AOSL
ALPHA & OMEGA SEMICONDUCTOR LTDTechnology$936M
0.03%
186REPL
REPLIMUNE GROUP INCHealthcare$859M
0.03%
187NX
QUANEX BUILDING PRODUCTS CORPBasic Materials$835M
0.03%
188FOXF
FOX FACTORY HOLDING CORPConsumer Cyclical$798M
0.03%
189CODI
COMPASS DIVERSIFIED HOLDINGSIndustrials$777M
0.03%
190SIBN
SI-BONE INCHealthcare$771M
0.03%
191BBNX
BETA BIONICS INCHealthcare$771M
0.03%
192KRT
KARAT PACKAGING INCConsumer Cyclical$760M
0.03%
193WEST
WESTROCK COFFEE COConsumer Defensive$749M
0.03%
194IBTA
IBOTTA INCTechnology$734M
0.03%
195CLYM
CLIMB BIO INCHealthcare$727M
0.03%
196AURA
AURA BIOSCIENCES INCHealthcare$723M
0.03%
197CBLL
CERIBELL INCHealthcare$710M
0.03%
198SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.02%
199SWBI
SMITH & WESSON BRANDS INCIndustrials$665M
0.02%
200CNNE
CANNAE HOLDINGS INCConsumer Cyclical$657M
0.02%
201HELE
HELEN OF TROY LTDConsumer Defensive$655M
0.02%
202EVH
EVOLENT HEALTH INCHealthcare$654M
0.02%
203TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.02%
204KLC
KINDERCARE LEARNING COMPANIES INCConsumer Defensive$618M
0.02%
205TECX
TECTONIC THERAPEUTIC INCHealthcare$615M
0.02%
206FAC
FACTORIAL ENERGY INCIndustrials$610M
0.02%
207RGR
STURM RUGER & CO INCIndustrials$604M
0.02%
208NTGR
NETGEAR INCTechnology$602M
0.02%
209NGNE
NEUROGENE INCHealthcare$590M
0.02%
210ALIT
ALIGHT INCTechnology$584M
0.02%
211MYGN
MYRIAD GENETICS INCHealthcare$584M
0.02%
212ANGO
ANGIODYNAMICS INCHealthcare$558M
0.02%
213RYAM
RAYONIER ADVANCED MATERIALS INCBasic Materials$555M
0.02%
214EGY
VAALCO ENERGY INCEnergy$553M
0.02%
215NPCE
NEUROPACE INCHealthcare$548M
0.02%
216YEXT
YEXT INCTechnology$535M
0.02%
217TOI
ONCOLOGY INSTITUTE INCHealthcare$535M
0.02%
218TASK
TASKUS INCTechnology$534M
0.02%
219ARVN
ARVINAS INCHealthcare$517M
0.02%
220DNA
GINKGO BIOWORKS HOLDINGS INCHealthcare$517M
0.02%
221RGNX
REGENXBIO INCHealthcare$511M
0.02%
222NVCT
NUVECTIS PHARMA INCHealthcare$508M
0.02%
223KIDS
ORTHOPEDIATRICS CORPHealthcare$494M
0.02%
224SGMT
SAGIMET BIOSCIENCES INCHealthcare$479M
0.02%
225OFIX
ORTHOFIX MEDICAL INCHealthcare$468M
0.02%
226IPI
INTREPID POTASH INCBasic Materials$459M
0.02%
227CLPT
CLEARPOINT NEURO INCHealthcare$454M
0.02%
228PRTA
PROTHENA CORP PUBLIC LTD COHealthcare$453M
0.02%
229KYTX
KYVERNA THERAPEUTICS INCHealthcare$453M
0.02%
230VREX
VAREX IMAGING CORPHealthcare$444M
0.02%
231CCRN
CROSS COUNTRY HEALTHCARE INCHealthcare$428M
0.02%
232ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.02%
233NVEC
NVE CORPTechnology$418M
0.01%
234CLFD
CLEARFIELD INCTechnology$416M
0.01%
235STRO
SUTRO BIOPHARMA INCHealthcare$391M
0.01%
236MGPI
MGP INGREDIENTS INCConsumer Defensive$382M
0.01%
237UPB
UPSTREAM BIO INCHealthcare$382M
0.01%
238EOLS
EVOLUS INCHealthcare$377M
0.01%
239CEPT
CANTOR EQUITY PARTNERS II INCIndustrials$376M
0.01%
240ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.01%
241ELMD
ELECTROMED INCHealthcare$349M
0.01%
242SEG
SEAPORT ENTERTAINMENT GROUP INCReal Estate$332M
0.01%
243XPOF
XPONENTIAL FITNESS INCConsumer Cyclical$328M
0.01%
244VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.01%
245LYEL
LYELL IMMUNOPHARMA INCHealthcare$311M
0.01%
246TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.01%
247SGHT
SIGHT SCIENCES INCHealthcare$274M
0.01%
248TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.01%
249HCKT
HACKETT GROUP INCTechnology$261M
0.01%
250SRZN
SURROZEN INCHealthcare$255M
0.01%
251RNAC
CARTESIAN THERAPEUTICS INCHealthcare$243M
0.01%
252ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.01%
253QUIK
QUICKLOGIC CORPTechnology$237M
0.01%
254GTE
GRAN TIERRA ENERGY INCEnergy$233M
0.01%
255RXST
RXSIGHT INCHealthcare$230M
0.01%
256SMTI
SANARA MEDTECH INCHealthcare$229M
0.01%
257UP
WHEELS UP EXPERIENCE INCIndustrials$229M
0.01%
258UTMD
UTAH MEDICAL PRODUCTS INCHealthcare$222M
0.01%
259KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.01%
260KROS
KEROS THERAPEUTICS INCHealthcare$211M
0.01%
261FOCL
FOCAL INCHealthcare$204M
0.01%
262ANIK
ANIKA THERAPEUTICS INCHealthcare$203M
0.01%
263AMWL
AMERICAN WELL CORPHealthcare$199M
0.01%
264PDEX
PRO DEX INCHealthcare$183M
0.01%
265EAF
GRAFTECH INTERNATIONAL LTDIndustrials$181M
0.01%
266INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.01%
267INGN
INOGEN INCHealthcare$178M
0.01%
268KRRO
KORRO BIO INCHealthcare$177M
0.01%
269AOUT
AMERICAN OUTDOOR BRANDS INCIndustrials$174M
0.01%
270ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.01%
271NLOP
NET LEASE OFFICE PROPERTIESReal Estate$172M
0.01%
272MRDN
MERIDIAN HOLDINGS INCCommunication Services$171M
0.01%
273RCEL
AVITA MEDICAL INCHealthcare$157M
0.01%
274DMRC
DIGIMARC CORPTechnology$133M
0.00%
275FIRY
FIRY INCTechnology$130M
0.00%
276AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.00%
277INSG
INSEEGO CORPTechnology$122M
0.00%
278STHO
STAR HOLDINGSReal Estate$114M
0.00%
279LAKE
LAKELAND INDUSTRIES INCConsumer Cyclical$113M
0.00%
280CPIX
CUMBERLAND PHARMACEUTICALS INCHealthcare$103M
0.00%
281CHRN
CHRONOSCALE CORPIndustrials$94M
0.00%
282GEOS
GEOSPACE TECHNOLOGIES CORPEnergy$88M
0.00%
283AEYE
AUDIOEYE INCTechnology$82M
0.00%
284PIII
P3 HEALTH PARTNERS INCHealthcare$78M
0.00%
285SEAT
VIVID SEATS INCCommunication Services$78M
0.00%
286ACET
ADICET BIO INCHealthcare$76M
0.00%
287AIRG
AIRGAIN INCTechnology$76M
0.00%
288CLNN
CLENE INCHealthcare$76M
0.00%
289SCLX
SCILEX HOLDING COHealthcare$72M
0.00%
290BGSF
BGSF INCIndustrials$65M
0.00%
291EDSA
EDESA BIOTECH INCHealthcare$59M
0.00%
292SKIL
SKILLSOFT CORPConsumer Defensive$58M
0.00%
293APT
ALPHA PRO TECH LTDBasic Materials$53M
0.00%
294MCRB
SERES THERAPEUTICS INCHealthcare$52M
0.00%
295EXOZ
EXOZYMES INCHealthcare$51M
0.00%
296TIL
INSTIL BIO INCHealthcare$50M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $2.83T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Healthcare
37.3%
Industrials
25.8%
Technology
14.9%
Basic Materials
14.4%
Consumer Defensive
3.0%
Financial Services
2.2%
Consumer Cyclical
1.3%
Communication Services
0.9%
Energy
0.2%
Real Estate
0.0%

Portfolio Style

Size × value map of the long-leg book

296 classified
Value
Blend
Growth
Large
Mid
Small
13%8
24%21
49%31
1%13
3%32
4%45
<1%41
1%30
<1%12

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 95% toward Large, 70% toward Growth. +6% unclassified (63 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt95% → Large
SmallLarge
Value ↔ growth tilt70% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
4
Failed
1
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    32.4%
    Margin
    -7.4%
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.2 (95% CI 1.0-1.4)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
11.3%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.17x
within
parametric
1.12x
within
cornish fisher
1.24x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2005
Before publication (pre-2005)
0.17
Sharpe · 4.1% p.a.
January 1999December 2005 · 84 mo
Since publication
-0.18
Sharpe · -2.4% p.a.
January 2006July 2026 · 247 mo
Change in Sharpe−0.35the return reversed sign — the published edge now runs the other way

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
35%
9 of 26 3-year windows made money
Worst window
-1.13
Sharpe, January 2003 – December 2005
January 1999July 2026
Median Sharpe
-0.20
Dispersion
0.56
Best window
0.97

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.30.7%13.4%
3 yearsp.a.14.4%-16.5%
5 yearsp.a.9.4%-2.5%
10 yearsp.a.10.3%-3.5%
Since inceptionp.a.7.2%-2.2%
Calendar years
YearLong legLong-short
20267 mo16.1%5.9%
202512.8%-16.8%
202414.1%-32.3%
202342.7%12.5%
2022-26.3%17.9%
202117.9%16.7%
20204.5%-31.1%
201926.8%9.5%
2018-10.4%5.2%
201717.8%-7.1%
201610.8%3.7%
20156.2%1.9%
201420.6%8.2%
201330.2%-5.7%
201215.4%-11.5%
2011-1.7%-6.7%
201015.4%-6.9%
200926.4%-7.4%
2008-38.8%-6.4%
200710.7%-8.9%
200622.7%13.3%
2005-1.1%-10.0%
20044.2%-16.4%
200335.9%-7.5%
2002-27.7%6.2%
2001-7.2%45.2%
2000-14.1%32.2%
199929.5%-23.6%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FDER
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2020-10-10 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$2.83T

Methodology

The Foundry DelEqu Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a DelEqu signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.